Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Cadherin-11 expression is upregulated in invasive human breast cancer.

Oncology letters

Pohlodek K, Tan YY, Singer CF, Gschwantler-Kaulich D.
PMID: 28101202
Oncol Lett. 2016 Dec;12(6):4393-4398. doi: 10.3892/ol.2016.5236. Epub 2016 Oct 10.

Loss of expression of cadherin-11 protein is correlated with a loss of epithelial phenotype and a gain in tumor cell proliferation and invasion. It has been hypothesized that cadherin-11 may be a molecular marker for a more aggressive subtype...

Cite
Pohlodek K, Tan YY, Singer CF, et al. Cadherin-11 expression is upregulated in invasive human breast cancer. Oncol Lett. 2016;12(6):4393-4398doi: 10.3892/ol.2016.5236.
Pohlodek, K., Tan, Y. Y., Singer, C. F., & Gschwantler-Kaulich, D. (2016). Cadherin-11 expression is upregulated in invasive human breast cancer. Oncology letters, 12(6), 4393-4398. https://doi.org/10.3892/ol.2016.5236
Pohlodek, Kamil, et al. "Cadherin-11 expression is upregulated in invasive human breast cancer." Oncology letters vol. 12,6 (2016): 4393-4398. doi: https://doi.org/10.3892/ol.2016.5236
Pohlodek K, Tan YY, Singer CF, Gschwantler-Kaulich D. Cadherin-11 expression is upregulated in invasive human breast cancer. Oncol Lett. 2016 Dec;12(6):4393-4398. doi: 10.3892/ol.2016.5236. Epub 2016 Oct 10. PMID: 28101202; PMCID: PMC5228198.
Copy Download .nbib Format: NLM
Corrigendum to "Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial" [Eur J Surg Oncol 42 (5) (2016) 665-671].

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Gschwantler-Kaulich D, Schrenk P, Bjelic-Radisic V, Unterrieder K, Leser C, Fink-Retter A, Salama M, Singer C.
PMID: 28526188
Eur J Surg Oncol. 2017 Jul;43(7):1380-1381. doi: 10.1016/j.ejso.2017.05.001. Epub 2017 May 16.

No abstract available.

Cite
Gschwantler-Kaulich D, Schrenk P, Bjelic-Radisic V, et al. Corrigendum to "Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial" [Eur J Surg Oncol 42 (5) (2016) 665-671]. Eur J Surg Oncol. 2017;43(7):1380-1381doi: 10.1016/j.ejso.2017.05.001.
Gschwantler-Kaulich, D., Schrenk, P., Bjelic-Radisic, V., Unterrieder, K., Leser, C., Fink-Retter, A., Salama, M., & Singer, C. (2017). Corrigendum to "Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial" [Eur J Surg Oncol 42 (5) (2016) 665-671]. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 43(7), 1380-1381. https://doi.org/10.1016/j.ejso.2017.05.001
Gschwantler-Kaulich, D, et al. "Corrigendum to "Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial" [Eur J Surg Oncol 42 (5) (2016) 665-671]." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 43,7 (2017): 1380-1381. doi: https://doi.org/10.1016/j.ejso.2017.05.001
Gschwantler-Kaulich D, Schrenk P, Bjelic-Radisic V, Unterrieder K, Leser C, Fink-Retter A, Salama M, Singer C. Corrigendum to "Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial" [Eur J Surg Oncol 42 (5) (2016) 665-671]. Eur J Surg Oncol. 2017 Jul;43(7):1380-1381. doi: 10.1016/j.ejso.2017.05.001. Epub 2017 May 16. PMID: 28526188.
Copy Download .nbib Format: NLM
Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers.

Molecular genetics & genomic medicine

Rieder V, Salama M, Glöckner L, Muhr D, Berger A, Tea MK, Pfeiler G, Rappaport-Fuerhauser C, Gschwantler-Kaulich D, Weingartshofer S, Singer CF.
PMID: 27066510
Mol Genet Genomic Med. 2015 Dec 10;4(2):172-7. doi: 10.1002/mgg3.191. eCollection 2016 Mar.

BACKGROUND: The birth year-dependent onset of breast cancer (BC) in BRCA1/2 mutation carriers suggests a risk-modifying role for reproductive and life style factors. We therefore examined possible associations between these factors and age at diagnosis.METHODS: Cox regression analysis and...

Cite
Rieder V, Salama M, Glöckner L, et al. Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers. Mol Genet Genomic Med. 2015;4(2):172-7doi: 10.1002/mgg3.191.
Rieder, V., Salama, M., Glöckner, L., Muhr, D., Berger, A., Tea, M. K., Pfeiler, G., Rappaport-Fuerhauser, C., Gschwantler-Kaulich, D., Weingartshofer, S., & Singer, C. F. (2016). Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers. Molecular genetics & genomic medicine, 4(2), 172-7. https://doi.org/10.1002/mgg3.191
Rieder, Viktoria, et al. "Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers." Molecular genetics & genomic medicine vol. 4,2 (2016): 172-7. doi: https://doi.org/10.1002/mgg3.191
Rieder V, Salama M, Glöckner L, Muhr D, Berger A, Tea MK, Pfeiler G, Rappaport-Fuerhauser C, Gschwantler-Kaulich D, Weingartshofer S, Singer CF. Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers. Mol Genet Genomic Med. 2015 Dec 10;4(2):172-7. doi: 10.1002/mgg3.191. eCollection 2016 Mar. PMID: 27066510; PMCID: PMC4799878.
Copy Download .nbib Format: NLM
Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.

PloS one

Gschwantler-Kaulich D, Weingartshofer S, Rappaport-Fürhauser C, Zeillinger R, Pils D, Muhr D, Braicu EI, Kastner MT, Tan YY, Semmler L, Sehouli J, Singer CF.
PMID: 29664962
PLoS One. 2018 Apr 17;13(4):e0196142. doi: 10.1371/journal.pone.0196142. eCollection 2018.

[This corrects the article DOI: 10.1371/journal.pone.0189641.].

Cite
Gschwantler-Kaulich D, Weingartshofer S, Rappaport-Fürhauser C, et al. Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers. PLoS One. 2018;13(4):e0196142doi: 10.1371/journal.pone.0196142.
Gschwantler-Kaulich, D., Weingartshofer, S., Rappaport-Fürhauser, C., Zeillinger, R., Pils, D., Muhr, D., Braicu, E. I., Kastner, M. T., Tan, Y. Y., Semmler, L., Sehouli, J., & Singer, C. F. (2018). Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers. PloS one, 13(4), e0196142. https://doi.org/10.1371/journal.pone.0196142
Gschwantler-Kaulich, Daphne, et al. "Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers." PloS one vol. 13,4 (2018): e0196142. doi: https://doi.org/10.1371/journal.pone.0196142
Gschwantler-Kaulich D, Weingartshofer S, Rappaport-Fürhauser C, Zeillinger R, Pils D, Muhr D, Braicu EI, Kastner MT, Tan YY, Semmler L, Sehouli J, Singer CF. Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers. PLoS One. 2018 Apr 17;13(4):e0196142. doi: 10.1371/journal.pone.0196142. eCollection 2018. PMID: 29664962; PMCID: PMC5903593.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries